Sri Harsha Tella
12PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Feb 24, 2024
Projected Incidence of Hepatobiliary Cancers and Trends Based on Age, Race, and Gender in the United States.Michael H Storandt, Sri Harsha Tella, Mikolaj A Wieczorek
|Jun 20, 2023
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.Sri Harsha Tella, Nathan Foster, Shi Qian
|Dec 06, 2022
Systemic Therapy in Advanced Hepatocellular Carcinoma: Patient Selection and Key Considerations.Michael H Storandt, Amit Mahipal, Sri Harsha Tella
|Oct 18, 2022
An evaluation of ivosidenib for the treatment of IDH1-mutant cholangiocarcinoma.Sri Harsha Tella, Amit Mahipal
|Jul 31, 2019
Medullary Thyroid Carcinoma: An Update on Imaging.Sergiy V Kushchayev, Yevgeniya S Kushchayeva, Sri Harsha Tella
|Mar 08, 2019
Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.Brian Chen, Sumimasa Nagai, James O Armitage
Pageof 2
Frequent Collaborators
3 joint publications
Zhaohui Jin
2 joint publications
Gaurav Goyal
2 joint publications
Michael H Storandt
1 joint publications
Jenny E Blau
1 joint publications
Simeon I Taylor
1 joint publications
Kristina I Rother
1 joint publications
Anuhya Kommalapati
1 joint publications
Charles L Bennett
1 joint publications
Sergiy V Kushchayev
1 joint publications
Shi Qian
